A61L 33/0041
Characterised by the choice of an antithrombatic agent other than heparin
Official title: {characterised by the choice of an antithrombatic agent other than heparin (heparinoïd A61L33/08; polypeptides A61L33/12)}
A61L33/0041 (Characterised by the choice of an antithrombatic agent other than heparin) appears on 83 US grants and 83 published applications in this corpus.
Search patents in A61L- Granted patents
- 83
- Published applications
- 83
- Assignees
- 76
- Inventors
- 241
- Latest grant
- 1 Sep 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1976 | 1 | 0 |
| 1977 | 0 | 0 |
| 1978 | 0 | 0 |
| 1979 | 0 | 0 |
| 1980 | 0 | 0 |
| 1981 | 2 | 0 |
| 1982 | 1 | 0 |
| 1983 | 0 | 0 |
| 1984 | 0 | 0 |
| 1985 | 1 | 0 |
| 1986 | 0 | 0 |
| 1987 | 0 | 0 |
| 1988 | 1 | 0 |
| 1989 | 1 | 0 |
| 1990 | 2 | 0 |
| 1991 | 1 | 0 |
| 1992 | 3 | 0 |
| 1993 | 2 | 0 |
| 1994 | 6 | 0 |
| 1995 | 3 | 0 |
| 1996 | 2 | 0 |
| 1997 | 1 | 0 |
| 1998 | 3 | 0 |
| 1999 | 2 | 0 |
| 2000 | 2 | 0 |
| 2001 | 2 | 3 |
| 2002 | 1 | 1 |
| 2003 | 3 | 3 |
| 2004 | 1 | 1 |
| 2005 | 2 | 0 |
| 2006 | 3 | 2 |
| 2007 | 0 | 5 |
| 2008 | 2 | 5 |
| 2009 | 0 | 5 |
| 2010 | 0 | 5 |
| 2011 | 1 | 1 |
| 2012 | 2 | 1 |
| 2013 | 1 | 2 |
| 2014 | 1 | 4 |
| 2015 | 3 | 2 |
| 2016 | 2 | 6 |
| 2017 | 3 | 4 |
| 2018 | 2 | 2 |
| 2019 | 2 | 3 |
| 2020 | 4 | 2 |
| 2021 | 4 | 8 |
| 2022 | 4 | 5 |
| 2023 | 1 | 5 |
| 2024 | 2 | 7 |
| 2025 | 1 | 0 |
| 2026 | 2 | 1 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Recent patents
- Robust nitric oxide-releasing polymers and articles and methods of making and uses thereof1 Sep 2026US 12,721,935 B2University of Georgia Research Foundation, Inc.
- Valve material with combined anti-clotting and anti-calcification properties and preparation method31 Mar 2026US 12,589,187 B2Jilin Venus Haoyue Medical Limited
- Clot adhesion preventing agent and blood collection container19 Aug 2025US 12,390,563 B2Sekisui Medical Co., Ltd.
- Bioprosthetic valve and preparation method thereof24 Sep 2024US 12,097,113 B2Sichuan University
- High anticoagulation extracorporeal circulation tube6 Feb 2024US 11,890,397 B1Wenzhou Safety (Emergency) Research Institute, Tianjin University
- Medical device and method for manufacturing the same21 May 2026US 2026/0137844 A1Terumo Kabushiki Kaisha
- Tissue-plasminogen activator coated catheter with hydrogel-controlled elution12 Dec 2024US 2024/0408286 A1Becton, Dickinson and Company
- Medical devices including therapeutic coatings for local delivery of a direct anticoagulant17 Oct 2024US 2024/0342348 A1Boston Scientific Scimed, Inc.
- Coating for medical devices11 Jul 2024US 2024/0226395 A1Smart Reactors Service Limited
- Method for grafting surface of medical device by using quaternized trimethylamine23 May 2024US 2024/0165306 A1Vasular Interface Inc.
Most cited
By later US patents
- Medical device with biomolecule-coated surface graft matrix281US 5,866,113 AMedtronic, Inc. · 1999
- Thermoplastic polymer composition and medical devices made of the same220US 5,417,981 ATerumo Kabushiki Kaisha · 1995
- Method of modifying the surface of a medical device193US 5,811,151 AMedtronic, Inc. · 1998
- Treatment of metallic surfaces using radiofrequency plasma deposition and chemical attachment of bioactive agents165US 5,336,518 ACordis Corporation · 1994
- Biocompatibility of solid surfaces146US 5,308,641 AMedtronic, Inc. · 1994